Literature DB >> 16698781

A mechanism for copper inhibition of infectious prion conversion.

Daniel L Cox, Jianping Pan, Rajiv R P Singh.   

Abstract

We employ ab initio electronic structure calculations to obtain two structural models for copper bound in the strongest binding site of the noninfectious form of the prion protein. The models are compatible with available experimental constraints from electron spin resonance data. The bending of the peptide backbone attendant with the copper binding is not compatible with the requisite straight beta-strand backbone structure for the same sequence contained in two recently proposed models of the prion protein structure in its infectious form. We hypothesize that copper binding at this site is protective against conversion to the infectious form, discuss experimental data that appear to support and conflict with our hypothesis, and propose tests using recombinant prion protein, genetically modified cultured neurons, and transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698781      PMCID: PMC1483082          DOI: 10.1529/biophysj.106.083642

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  23 in total

1.  Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems.

Authors:  F Horn; G Vriend; F E Cohen
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Self-consistent order-N density-functional calculations for very large systems.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1996-04-15

3.  Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.

Authors:  Olga V Bocharova; Leonid Breydo; Vadim V Salnikov; Ilia V Baskakov
Journal:  Biochemistry       Date:  2005-05-10       Impact factor: 3.162

4.  Imbalance of antioxidant defense in mice lacking cellular prion protein.

Authors:  F Klamt; F Dal-Pizzol; M L Conte da Frota; R Walz; M E Andrades; E G da Silva; R R Brentani; I Izquierdo; J C Fonseca Moreira
Journal:  Free Radic Biol Med       Date:  2001-05-15       Impact factor: 7.376

5.  Aberrant metal binding by prion protein in human prion disease.

Authors:  B S Wong; S G Chen; M Colucci; Z Xie; T Pan; T Liu; R Li; P Gambetti; M S Sy; D R Brown
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

6.  Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice.

Authors:  S Supattapone; P Bosque; T Muramoto; H Wille; C Aagaard; D Peretz; H O Nguyen; C Heinrich; M Torchia; J Safar; F E Cohen; S J DeArmond; S B Prusiner; M Scott
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

7.  Copper chelation delays the onset of prion disease.

Authors:  Einar M Sigurdsson; David R Brown; Muhammad A Alim; Henrieta Scholtzova; Richard Carp; Harry C Meeker; Frances Prelli; Blas Frangione; Thomas Wisniewski
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

8.  Copper coordination in the full-length, recombinant prion protein.

Authors:  Colin S Burns; Eliah Aronoff-Spencer; Giuseppe Legname; Stanley B Prusiner; William E Antholine; Gary J Gerfen; Jack Peisach; Glenn L Millhauser
Journal:  Biochemistry       Date:  2003-06-10       Impact factor: 3.162

9.  Prion infection impairs copper binding of cultured cells.

Authors:  Walid Rachidi; Alain Mangé; Abderrahmene Senator; Pascale Guiraud; Jacqueline Riondel; Mustapha Benboubetra; Alain Favier; Sylvain Lehmann
Journal:  J Biol Chem       Date:  2003-03-10       Impact factor: 5.157

10.  Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform.

Authors:  E Quaglio; R Chiesa; D A Harris
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

View more
  12 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

Review 2.  Insights into prion protein function from atomistic simulations.

Authors:  Miroslav Hodak; Jerzy Bernholc
Journal:  Prion       Date:  2010-01-16       Impact factor: 3.931

Review 3.  Copper and the prion protein: methods, structures, function, and disease.

Authors:  Glenn L Millhauser
Journal:  Annu Rev Phys Chem       Date:  2007       Impact factor: 12.703

Review 4.  Copper binding extrinsic to the octarepeat region in the prion protein.

Authors:  Eric D Walter; Dan J Stevens; Ann R Spevacek; Micah P Visconte; Andrew Dei Rossi; Glenn L Millhauser
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

5.  Probing structural differences in prion protein isoforms by tyrosine nitration.

Authors:  Christopher W Lennon; Holly D Cox; Scott P Hennelly; Sam J Chelmo; Michele A McGuirl
Journal:  Biochemistry       Date:  2007-03-31       Impact factor: 3.162

Review 6.  Prion stability and infectivity in the environment.

Authors:  Richard C Wiggins
Journal:  Neurochem Res       Date:  2008-05-16       Impact factor: 3.996

7.  Fragment length influences affinity for Cu2+ and Ni2+ binding to His96 or His111 of the prion protein and spectroscopic evidence for a multiple histidine binding only at low pH.

Authors:  Mark Klewpatinond; John H Viles
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

8.  Studying the Cu binding sites in the PrP N-terminal region: a test case for ab initio simulations.

Authors:  S Furlan; G La Penna; F Guerrieri; S Morante; G C Rossi
Journal:  Eur Biophys J       Date:  2007-05-10       Impact factor: 2.095

9.  Mechanism of copper(II)-induced misfolding of Parkinson's disease protein.

Authors:  Frisco Rose; Miroslav Hodak; Jerzy Bernholc
Journal:  Sci Rep       Date:  2011-06-14       Impact factor: 4.379

10.  The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion.

Authors:  Gabriele Giachin; Phuong Thao Mai; Thanh Hoa Tran; Giulia Salzano; Federico Benetti; Valentina Migliorati; Alessandro Arcovito; Stefano Della Longa; Giordano Mancini; Paola D'Angelo; Giuseppe Legname
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.